Clinical TrialsSearch results
Number of results: 322
Other
- Phase II study of a combination of CPT-11 and S-1 and bevacizumab in patients with metastatic colon cancer.
- metastatic colorectal cancer
- Niigata Colorectal cancer Chemotherapy Study Group (NCCSG)
- 2009-01-14
Other
- Phase II prospective treatment study for IgG4+MOLPS
- IgG4+MOLPS (IgG4+Multiorgan lymphoproliferative syndrome)
- Department of Hematology and Immunology, Kanazawa Medical University
- 2009-08-10
Other
- Phase II clinical trials of mature B-cell neoplasms in children: A Japanese Cooperative Studies
- mature B-cell non-Hodgkin's lymphoa
- Japanese Pediatric Leukemia/Lymphoma Studu Group(JPLSG)
- 2006-02-05
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Phase II clinical trial of interleukin-2, interferon-alpha and tegafur uracil therapy for advanced renal cell cancer
- advanced renal cell cancer
- Department of Urology Faculty of Medicine
- 2009-07-21
Other
- Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study
- Advanced stage lymphoblastic lymphoma of children.
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Other
- Phase I/II Study of Topotecan and Ifosfamide in Pediatric Patients with Relapsed or Refractory Solid Tumors
- Relapse/ refractory pediatric solid tumor
- Group for "making evidence for the drugs which are available in clinical practice in Europe and USA but not available in Japan"
- 2008-02-16
Other
- Phase I/II Study of S-1, Cisplatin and Docetaxel in Patients with Advanced Gastric Cancer
- untreated advanced or recurrent gastric cancer
- Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama
- 2006-09-11
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Recruiting
- Phase 2 Study of Niraparib in Recurrent or Persistent Rare Gynecologic Malignancies with Homologous Recombination Deficiency
- uterine leiomyosarcoma, endometrial cancer(Ca), uterine sarcoma, cervical Ca, vulva vaginal Ca
- Enomoto Takayuki
- 2021-08-20